Aldo Torre

4.4k total citations
81 papers, 2.5k citations indexed

About

Aldo Torre is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Aldo Torre has authored 81 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hepatology, 52 papers in Epidemiology and 30 papers in Surgery. Recurrent topics in Aldo Torre's work include Liver Disease Diagnosis and Treatment (51 papers), Liver Disease and Transplantation (46 papers) and Organ Transplantation Techniques and Outcomes (21 papers). Aldo Torre is often cited by papers focused on Liver Disease Diagnosis and Treatment (51 papers), Liver Disease and Transplantation (46 papers) and Organ Transplantation Techniques and Outcomes (21 papers). Aldo Torre collaborates with scholars based in Mexico, Spain and United States. Aldo Torre's co-authors include Pere Ginès, Vicente Arroyo, Marta Martín–Llahí, Juan Rodés, Carlos Terra, Mónica Guevara, Andrés Duarte‐Rojo, Ricardo Ulises Macías‐Rodríguez, Astrid Ruiz‐Margáin and Mónica Guevara and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Aldo Torre

77 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aldo Torre Mexico 24 1.8k 1.6k 847 338 321 81 2.5k
Rakhi Maiwall India 30 1.8k 1.0× 1.6k 1.0× 722 0.9× 105 0.3× 308 1.0× 140 2.7k
Alain Braillon France 25 1.5k 0.8× 1.3k 0.8× 844 1.0× 232 0.7× 144 0.4× 112 2.1k
Pratima Sharma United States 31 2.3k 1.3× 1.5k 0.9× 1.6k 1.9× 109 0.3× 193 0.6× 106 3.1k
Veit Gülberg Germany 24 1.9k 1.0× 1.4k 0.9× 1.3k 1.5× 192 0.6× 307 1.0× 52 2.3k
Alastair O’Brien United Kingdom 21 1.1k 0.6× 1.1k 0.7× 460 0.5× 176 0.5× 137 0.4× 64 1.9k
Bent Adel Hansen Denmark 26 1.6k 0.9× 891 0.6× 860 1.0× 235 0.7× 156 0.5× 45 2.5k
R. Todd Frederick United States 12 1.4k 0.8× 1.3k 0.8× 746 0.9× 53 0.2× 85 0.3× 28 1.7k
Laurence Piéroni France 17 958 0.5× 1.3k 0.9× 200 0.2× 270 0.8× 501 1.6× 55 2.5k
Conrado Fernández‐Rodríguez Spain 25 1.5k 0.8× 1.5k 1.0× 476 0.6× 108 0.3× 38 0.1× 93 2.5k
Paul Kerlin Australia 29 612 0.3× 464 0.3× 1.9k 2.2× 328 1.0× 105 0.3× 80 3.4k

Countries citing papers authored by Aldo Torre

Since Specialization
Citations

This map shows the geographic impact of Aldo Torre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldo Torre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldo Torre more than expected).

Fields of papers citing papers by Aldo Torre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aldo Torre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldo Torre. The network helps show where Aldo Torre may publish in the future.

Co-authorship network of co-authors of Aldo Torre

This figure shows the co-authorship network connecting the top 25 collaborators of Aldo Torre. A scholar is included among the top collaborators of Aldo Torre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aldo Torre. Aldo Torre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Torre, Aldo, et al.. (2025). Hepatic encephalopathy: risk identification and prophylaxis approaches. Metabolic Brain Disease. 40(3). 138–138. 2 indexed citations
3.
Torre, Aldo, et al.. (2024). Pirfenidone use in fibrotic diseases: What do we know so far?. Immunity Inflammation and Disease. 12(7). e1335–e1335. 13 indexed citations
4.
Cao, Zhujun, Florence Wong, Ashok Choudhury, et al.. (2024). Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium. ˜The œLancet. Gastroenterology & hepatology. 9(11). 997–1009. 11 indexed citations
5.
Olivas‐Martínez, Antonio, Carlos Moctezuma‐Velázquez, Graciela Castro‐Narro, et al.. (2022). Prevalence of Metabolic-associated Fatty Liver Disease in Mexico and Development of a Screening Tool: The MAFLD-S Score. SHILAP Revista de lepidopterología. 1(3). 352–358. 10 indexed citations
6.
Vilatobá, Mario, et al.. (2022). Liver transplantation is beneficial regardless of cirrhosis stage or acute-on-chronic liver failure grade: A single-center experience. World Journal of Gastroenterology. 28(40). 5881–5892. 11 indexed citations
7.
Tijera, Fátima Higuera-de la, Jacqueline Córdova‐Gallardo, Beatriz Barranco-Fragoso, et al.. (2021). Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value. Digestive Diseases and Sciences. 66(12). 4501–4507. 15 indexed citations
8.
Méndez-Guerrero, Osvely, et al.. (2020). Renal and brain failure predict mortality of patients with acute-on-chronic liver failure admitted to the intensive care unit. Annals of Hepatology. 22. 100270–100270. 14 indexed citations
9.
Ruiz‐Margáin, Astrid, et al.. (2018). Manejo dietético y suplementación con aminoácidos de cadena ramificada en cirrosis hepática. Revista de Gastroenterología de México. 83(4). 424–433. 10 indexed citations
10.
Remes-Troche, J.M., et al.. (2017).  Elevated circulating levels of IL-21 and IL-22 define a cytokine signature profile in type 2 autoimmune hepatitis patients.. SHILAP Revista de lepidopterología. 15(4). 550–8. 20 indexed citations
11.
Ruiz‐Margáin, Astrid, Ricardo Ulises Macías‐Rodríguez, Javier Ampuero, et al.. (2016). Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis. World Journal of Gastroenterology. 22(45). 10064–10064. 31 indexed citations
12.
Rivera-Espinosa, Liliana, et al.. (2016). Intestinal permeability in a patient with liver cirrhosis. Therapeutics and Clinical Risk Management. Volume 12. 1729–1748. 38 indexed citations
13.
Torre, Aldo, et al.. (2011). Prevalencia de la hepatitis por virus B en pacientes con cirrosis en México. Revista Médica Del Hospital General De México. 74(1). 16–20. 3 indexed citations
14.
Martín–Llahí, Marta, Mónica Guevara, Aldo Torre, et al.. (2010). Prognostic Importance of the Cause of Renal Failure in Patients With Cirrhosis. Gastroenterology. 140(2). 488–496.e4. 259 indexed citations
15.
Guevara, Mónica, María E. Baccaro, Aldo Torre, et al.. (2009). Hyponatremia Is a Risk Factor of Hepatic Encephalopathy in Patients With Cirrhosis: A Prospective Study With Time-Dependent Analysis. The American Journal of Gastroenterology. 104(6). 1382–1389. 170 indexed citations
16.
Torre, Aldo, et al.. (2007). Avances en la fisiopatología de la encefalopatía hepática. 20(3). 3. 1 indexed citations
17.
Torre, Aldo. (2007). La genesi dello spazio: il miracolo dell'ostia (Asti, 10 maggio 1718). Quaderni storici. 42(125). 355–392.
18.
Arroyo, Vicente, Carlos Terra, & Aldo Torre. (2005). Soporte circulatorio con albúmina en la cirrosis hepática. Gastroenterología y Hepatología. 28(2). 74–79. 1 indexed citations
19.
Terra, Carlos, Mónica Guevara, Aldo Torre, et al.. (2005). Renal Failure in Patients With Cirrhosis and Sepsis Unrelated to Spontaneous Bacterial Peritonitis: Value of MELD Score. Gastroenterology. 129(6). 1944–1953. 188 indexed citations
20.
Restuccia, Tea, Beatriz Gómez‐Ansón, Mónica Guevara, et al.. (2004). Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis. Hepatology. 39(6). 1613–1622. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rakhi Maiwall Breakdown of academic impact, for papers by Alain Braillon Breakdown of academic impact, for papers by Pratima Sharma Breakdown of academic impact, for papers by Veit Gülberg Breakdown of academic impact, for papers by Alastair O’Brien Breakdown of academic impact, for papers by Bent Adel Hansen Breakdown of academic impact, for papers by R. Todd Frederick Breakdown of academic impact, for papers by Laurence Piéroni Breakdown of academic impact, for papers by Conrado Fernández‐Rodríguez Breakdown of academic impact, for papers by Paul Kerlin
Rankless by CCL
2026